跳至主要内容
临床试验/EUCTR2021-003407-17-DK
EUCTR2021-003407-17-DK进行中(未招募)1 期

Combined effects of potassium, nitrate and sodium on blood pressure in patients with hypertension - KANSA

niversity Clinic of Nephrology and Hypertension0 个研究点目标入组 120 人开始时间: 2022年2月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males or females, =18 years
  • Body mass index = 35 kg/m2
  • Essential hypertension (current treatment with a maximum of 3 antihypertensive drugs or newly diagnosed)
  • Capable of adhering to a dietary regimen
  • Albumin-to-creatinine-ratio < 500 mg/g
  • Safe contraception if women in childbearing age
  • eGFR > 60 ml/min/1,73m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • Secondary hypertension
  • Clinically significant heart failure (NYHA 3-4)
  • Diabetes mellitus (type 1 and 2)
  • Clinically significant liver disease
  • Current malignant disease (other than skin cancer)
  • Renal transplant
  • Recent stroke, transient ischemic attack or myocardial infarction (past 6 months)
  • Immunosuppressive treatment
  • Pregnancy or lactation
  • Alcohol abuse
  • Nitroglycerin or slow-release nitrate treatment
  • Treatment with other medications that might interact with results and which cannot be paused during the intervention due to safety reasons.
  • CKD due to other cause than hypertension

研究者

发起方
niversity Clinic of Nephrology and Hypertension

相似试验

Combined effects of potassium, nitrate and sodium on... | 临床试验